Substance / Medication

Pyrantel tartrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Anal Albendazole application for pruritus ani in threadworm infestation.
Singh Shivaram Prasad, Panda Chittaranjan, Rout Niranjan et al. · J Trop Pediatr · 2005
PMID: 15958409RCT
Activity of selected antioxidative enzymes in rats exposed to dimethoate and pyrantel tartrate.
Barski D, Spodniewska A · Pol J Vet Sci · 2012
PMID: 22844700Preclinical
Pyrantel pamoate resistance in horses receiving daily administration of pyrantel tartrate.
Brazik Emily L, Luquire Jan T, Little Dianne · J Am Vet Med Assoc · 2006
PMID: 16426178Preclinical
Effect of daily administration of pyrantel tartrate in preventing infection in horses experimentally challenged with Sarcocystis neurona.
Rossano Mary G, Schott Harold C, Kaneene John B et al. · Am J Vet Res · 2005
PMID: 15934612Preclinical
The effects of pyrantel tartrate on Sarcocystis neurona merozoite viability.
Kruttlin E A, Rossano M G, Murphy A J et al. · Vet Ther · 2001
PMID: 19746670Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pyrantel tartrate (substance)
SNOMED CT
96117000
UMLS CUI
C0034238

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.